Expanded Access Part 2
Rebecca Rogers, IRB Chair at Schulman IRB, will discuss expanded access for intermediate and large patient populations and early/expanded access of devices.
The industry’s choice for
central and local IRB services.
By combining quality reviews with global consulting services, uniquely responsive client service and proprietary, Part 11 compliant technology tools, we are able to both improve human subject protection and allow our clients to reach their business goals.
We've been serving the clinical trial industry since 1983.
Our technology tools deliver unparalleled visibility and efficiency.
We complete thorough, ethical reviews as swiftly as possible.
The Schulman IRB Webinar Series offers timely information to study sponsors, CRO representatives, investigators and institutional personnel in an engaging, easy-to-parse format.
CLICK HERE to see our full webinar archive, as well as to register for upcoming sessions.
In response to client feedback, Schulman IRB has improved its submission forms for study status reporting and subject safety reports.Read More
Schulman IRB has improved its services for clients updating sub-investigator (sub-I) and site location information for ongoing studies under Schulman's oversight.Read More